Richard Stewart
2018
In 2018, Richard Stewart earned a total compensation of $1.1M as Chairman and Chief Executive Officer at OncoGenex Pharmaceuticals, a 423% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $272,640 |
|---|---|
| Option Awards | $317,625 |
| Salary | $500,000 |
| Total | $1,090,265 |
Stewart received $500K in salary, accounting for 46% of the total pay in 2018.
Stewart also received $272.6K in non-equity incentive plan and $317.6K in option awards.
Rankings
In 2018, Richard Stewart's compensation ranked 8,789th out of 14,244 executives tracked by ExecPay. In other words, Stewart earned more than 38.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,789 out of 14,244 | 38th |
Division Manufacturing | 3,504 out of 5,762 | 39th |
Major group Chemicals And Allied Products | 1,325 out of 2,125 | 38th |
Industry group Drugs | 1,109 out of 1,814 | 39th |
Industry In Vitro and In Vivo Diagnostic Substances | 33 out of 72 | 54th |
Source: SEC filing on March 28, 2019.
Stewart's colleagues
We found three more compensation records of executives who worked with Richard Stewart at OncoGenex Pharmaceuticals in 2018.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019